Joanna Szabo  |  October 16, 2020

Category: Breast Implants

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

What are textured breast implants?

Breast cancer patients go through enough—they don’t need the additional worry of potential increased breast implant cancer recurrence risk. But breast cancer patients who undergo post mastectomy reconstruction with textured breast implants may unfortunately face just such a risk, according to a South Korean retrospective study.

Textured Breast Implants

Textured breast implants are used during breast augmentation surgery. These implants are placed either behind the breast tissue or underneath the chest muscle. There are many types of breast implants, including smooth, round, shaped, saline, silicone, and textured.

Textured breast implants in particular are intended to help the implants adhere to the surrounding tissue, helping prevent apparent unnatural movement or rotation.

Do Breast Implants Increase Cancer Risk?

According to a recent retrospective study from South Korea, which looked at data on 650 women who received breast implants, 4 percent had some form of disease recurrence in a follow-up exam, a median of 52 months after surgery.

The study found that the locoregional recurrence-free survival (LRRFS) rate was 95.9 percent among those who received textured breast implants, while it was 97.8 percent among those who received smooth implants. Sa Ik Bang, MD, PhD, of Sungkyunkwan University and Samsung Medical Center in Seoul, along with colleagues, reported that these figures made up a nonsignificant difference.

The 5-year disease-free survival (DFS) rate was significantly lower with textured implants, according to the study, published online in JAMA Surgery. Textured implants were associated with a 93.3 percent 5-year DFS rate, compared with a 97.8 percent rate in those with smooth implants. This significant difference was seen at 3, 4, and 5 years, according to researchers.

“Textured implant use could be associated with a lower DFS and high risk for recurrence than use of a smooth implant,” the researchers concluded. “This association may be valid regardless of other factors, including tumor stage and ER [estrogen receptor] status. Further investigation is required to verify these results.”

This research adds to a growing pile of studies looking into the risk of anaplastic large-cell lymphoma (ALCL) that has been linked with breast implants. So far, Breast Implant Associated ALCL has accounted for 733 cases of ALCL, along with 36 deaths across the globe as of early 2020, per the U.S. Food and Drug Administration (FDA).

The FDA requested that Allergan recall its BIOCELL textured breast implants and tissue expanders, which Allergan agreed to in July 2019, removing these products from the global market.

Commentary accompanying the article by Bang and colleagues discussed what this adverse data means for the use of textured breast implants.

What are textured breast implants?“Given the association of textured implants with ALCL, and now the suggestion that they are associated with increased risk for breast cancer recurrence, surgeons who choose textured implants should counsel their patients with breast cancer about their possible consequences,” according to Michael R. Cassidy, MD, and Daniel S. Roh, MD, PhD, both of Boston University School of Medicine. “Many reconstructive surgeons across the world have already abandoned the use of textured implants altogether.”

It is unclear what exactly triggers BIA-ALCL, though chronic inflammation from an implant or the surgical procedure itself has been hypothesized as a potential trigger.

Along with the risk of BIA-ALCL, potentially associated with the use of textured breast implants, some patients are also concerned about whether or not these textured breast implants may increase the risk of breast cancer recurrence when used in post mastectomy reconstruction procedures.

So far, no clinical studies have examined the association between breast implants and breast cancer recurrence.

Filing a Textured Breast Implant Lawsuit

A growing number of patients are pursuing litigation after being diagnosed cancer following use of textured breast implants.

If you or someone you love has developed a breast implant–related illness, especially BIA-ALCL, after getting textured breast implants, you may be able to file a lawsuit and pursue compensation. While filing a lawsuit cannot take away the pain and suffering caused by cancer, nor can it bring a loved one back to life, it can at least help to alleviate the financial burden incurred by medical expenses, lost wages, and more.

Filing a lawsuit can seem like a daunting prospect, especially in the wake of a cancer diagnosis, so Top Class Actions has laid the groundwork for you by connecting you with an experienced attorney. Consulting an attorney can help you determine if you have a claim, navigate the complexities of litigation, and maximize your potential compensation.

Join a Free Breast Implants Side Effects Lawsuit Investigation

You may qualify for this breast implant investigation under these circumstances: 

  • You were implanted with BIOCELLE or Natrelle textured breast implants; 
  • You were diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA ALCL); or
  • You have had revision surgery after learning about this cancer risk.

Fill out the form on this page for a free case evaluation by a breast implants injury attorney. 

Get a Free Case Evaluation

This article is not legal advice. It is presented
for informational purposes only.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Get Help – It’s Free

Join a Free Breast Implants Side Effects Lawsuit Investigation

If you qualify, an attorney will contact you to discuss the details of your potential case at no charge to you.

PLEASE NOTE: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client or getting you dropped as a client.

E-mail any problems with this form to:
Questions@TopClassActions.com.

  • The law firms responsible for the content of this page are:
    LegaFi Law LLC (an Arizona law firm)
    888-4-LegaFi
    legafi.com
    and
    Levin Papantonio Rafferty Proctor Buchanan O'Brien Barr Mougey, P.A.
    Pensacola, FL
    800-277-1193
    levinlaw.com
  • Hidden
  • Please note that if you were not implanted with textured breast implants, you will not qualify for this investigation.
  • We tell you about cash you can claim every week! Subscribe to our free newsletter today.
    By checking this box, I consent to receive from Top Class Actions marketing emails and/or marketing calls or text messages sent by an automatic telephone dialing system. I consent to Top Class Actions providing my phone number and email address to the lawyers or their agents sponsoring this investigation, and their co-counsel, if any, and I consent to receive marketing calls, text messages, and/or emails from those lawyers or their agents. I understand that this authorization overrides any previous registrations on a federal or state Do Not Call registry. You may opt out at any time. You can review Top Class Actions' Terms and Conditions and Privacy Policy here.
  • This field is for validation purposes and should be left unchanged.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.